These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33486451)

  • 1. Prevalence of thyroid cancer in patients with acromegaly and non-growth hormone secreting pituitary adenomas: A prospective cross-sectional study.
    Spricido IY; Feckinghaus CM; Silva RHM; Mesa Junior CO; Boguszewski CL
    Growth Horm IGF Res; 2021 Feb; 56():101378. PubMed ID: 33486451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.
    Gasperi M; Martino E; Manetti L; Arosio M; Porretti S; Faglia G; Mariotti S; Colao AM; Lombardi G; Baldelli R; Camanni F; Liuzzi A;
    J Endocrinol Invest; 2002 Mar; 25(3):240-5. PubMed ID: 11936466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiated thyroid carcinoma in sporadic and familial presentations of acromegaly: A case series.
    Rogozinski A; Daly AF; Reyes A; Furioso A; Beckers A; Lowenstein A
    Ann Endocrinol (Paris); 2020 Oct; 81(5):482-486. PubMed ID: 32822652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.
    Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable?
    Reverter JL; Fajardo C; Resmini E; Salinas I; Mora M; Llatjós M; Sesmilo G; Rius F; Halperin I; Webb SM; Ricart V; Riesgo P; Mauricio D; Puig-Domingo M
    PLoS One; 2014; 9(8):e104174. PubMed ID: 25127456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the thyroid characteristics of patients with growth hormone-secreting adenomas.
    Xu D; Wu B; Li X; Cheng Y; Chen D; Fang Y; Du Q; Chen Z; Wang X
    BMC Endocr Disord; 2019 Sep; 19(1):94. PubMed ID: 31477080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary neuroendocrine tumors and differentiated thyroid cancer: do metabolic and inflammatory risk factors play roles?
    Cortês Nascimento G; de Araujo Cortês Nascimento AGP; de Maria Ribeiro Veiga Parente C; Rodrigues VP; de Sousa Azulay RS; de Carvalho Rocha VC; da Silva Pereira Damianse S; Magalhães M; Dos Santos Faria M; Gomes MB
    J Endocrinol Invest; 2021 Apr; 44(4):735-744. PubMed ID: 32681462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
    Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
    Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients.
    Dogan S; Atmaca A; Dagdelen S; Erbas B; Erbas T
    Endocrine; 2014 Feb; 45(1):114-21. PubMed ID: 23670709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid nodules in acromegaly.
    Rogozinski A; Furioso A; Glikman P; Junco M; Laudi R; Reyes A; Lowenstein A
    Arq Bras Endocrinol Metabol; 2012 Jul; 56(5):300-4. PubMed ID: 22911282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
    Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elastosonographic evaluation of thyroid nodules in acromegaly.
    Scacchi M; Andrioli M; Carzaniga C; Vitale G; Moro M; Poggi L; Pecori Giraldi F; Fatti LM; Cavagnini F
    Eur J Endocrinol; 2009 Oct; 161(4):607-13. PubMed ID: 19666699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of differentiated thyroid carcinoma in acromegaly.
    Tita P; Ambrosio MR; Scollo C; Carta A; Gangemi P; Bondanelli M; Vigneri R; degli Uberti EC; Pezzino V
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):161-7. PubMed ID: 16060909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acromegaly and thyroid disease: prevalence of thyroid cancer].
    Marchisotti FG; Umeda LM; Zach PL; Saldanha MD; First OS; Liberman B
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):843-9. PubMed ID: 16444369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NO BENEFIT OF DEDICATED THYROID NODULE SCREENING IN PATIENTS WITH ACROMEGALY.
    Lai NB; Garg D; Heaney AP; Bergsneider M; Leung AM
    Endocr Pract; 2020 Jan; 26(1):16-21. PubMed ID: 31461359
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroid cancer in patients with acromegaly: a case-control study.
    dos Santos MC; Nascimento GC; Nascimento AG; Carvalho VC; Lopes MH; Montenegro R; Montenegro R; Vilar L; Albano MF; Alves AR; Parente CV; dos Santos Faria M
    Pituitary; 2013 Mar; 16(1):109-14. PubMed ID: 22527615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of thyroid disease and thyroid malignancy in acromegalic patients.
    Cankurtaran Y; Örük GG; Tozduman B
    Minerva Endocrinol (Torino); 2023 Jun; 48(2):130-139. PubMed ID: 33988006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACTH response to desmopressin in a patient with acromegaly; expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma.
    Arihara Z; Sakurai K; Osaki Y; Fukazawa H; Yamada S; Inoshita N; Murakami O; Ohba K; Takahashi K
    Endocr J; 2011; 58(12):1029-36. PubMed ID: 21908929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI of pituitary adenomas in acromegaly.
    Marro B; Zouaoui A; Sahel M; Crozat N; Gerber S; Sourour N; Sag K; Marsault C
    Neuroradiology; 1997 Jun; 39(6):394-9. PubMed ID: 9225316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of coexistence of TSH/GH-secreting pituitary tumor and papillary thyroid carcinoma: Challenges in pathogenesis and management.
    Kiatpanabhikul P; Shuangshoti S; Chantra K; Navicharern P; Kingpetch K; Houngngam N; Snabboon T
    J Clin Neurosci; 2017 Jul; 41():78-80. PubMed ID: 28279554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.